Tuesday, February 11, 2025, 10:39PM |  33°
MENU
Advertisement
A female Aedes aegypti mosquito is in the process of acquiring a blood meal from a human host. The Aedes aegypti mosquito is behind the large outbreaks of the Zika virus in Latin America and the Caribbean.
1
MORE

Pitt announces two promising Zika vaccines

James Gathany/Centers for Disease Control and Prevention via AP

Pitt announces two promising Zika vaccines

Amid the growing surge of Zika research, the University of Pittsburgh School of Medicine has announced early success with two experimental vaccines that prevented the pups of immunized female mice from becoming infected with the virus.

Both vaccines, with one more effective than the other, succeeded in producing an immune response to the virus that was transferred from mother to her pups. That would represent an important goal in a human vaccine, given the severe neurological birth defects including microcephaly (an abnormally small head) and Guillan-Barre syndrome that the viral infection can cause.

“We’ve not only developed a promising vaccine candidate to move toward larger pre-clinical and, eventually, human clinical trials, but also a delivery format that would be inexpensive to produce and distribute to hundreds of thousands of people,” said Andrea Gambotto, an associate professor of surgery at the medical school who was senior author of the study, published online Monday in the EBioMedicine journal.

Advertisement

Congress recently allocated $1.1 billion for Zika research, money that Pitt researchers hope to tap to advance their vaccines to human clinical trials, potentially within a year, Dr. Gambotto said.

Runners cast long shadows along Fort Pitt Boulevard during the annual Richard S. Caliguiri City of Pittsburgh Great Race on Sept. 25.
Joyce Gannon
Caliguiri Fund to help spur Pitt research into fatal disease

The Pitt focus is creating a vaccine given to the mother that protects the fetus and newborn against birth defects. So far, so good.

“Pups born to mice immunized with [the one Pitt vaccine] were all protected against lethal challenge infection without weight loss or neurological signs,” while 50 percent of the pups born to dams immunized with the second Pitt virus were protected, the study says.

One vaccine involved a standard injection. The other used crystals affixed to a patch similar to a Band-Aid to keep them in contact with the skin until they dissolved.

Advertisement

The vaccines generate an immune response against an antigen — a protein — on the outer shell of the virus. The Pitt study describes the immunization as “a promising candidate vaccine” for the prevention of Zika virus disease.

Bites from mosquitoes of the Aedes species represent the key method of viral transmission, with sexual transmission also possible. Various South American, Central American and Caribbean nations are experiencing epidemic levels of infection, while Florida has reported Zika infections contracted from local mosquitoes. The virus already has spread to 50 nations, with 6,400 cases in the United States and its territories, the National institute of Health reports.

The National Institute of Allergy and Infectious Diseases currently is working on five Zika vaccines, with the Aug. 2 launch of a human clinical trial.

Once a vaccine is developed, it typically is tested in mice then monkeys. If successful, the next step is three phases of human clinical trials to determine safety and effectiveness before it goes before the U.S. Food and Drug Administration for approval. Even if the institute’s vaccine proceeds on the current fast track, its effectiveness on humans won’t be clear until early to mid-2018, said institute director Anthony S. Fauci. Consider, however, that vaccines typically take seven to 10 years to be developed and approved.

Developing a Zika virus poses no serious difficulties in vaccine science, given that similar flavivirus vaccines already have been developed for yellow fever and several types of encephalitis.

Besides the five NIH vaccines, pharmaceutical companies, universities and others also have reported their development of vaccines.

“The more shots on goal you have, the better the chance of getting a vaccine,” Dr. Fauci said. “If history holds true, there should be an effective vaccine against Zika.”

David Templeton: dtempleton@post-gazette.com or 412-263-1578.

First Published: October 3, 2016, 6:00 p.m.
Updated: October 4, 2016, 4:07 a.m.

RELATED
SHOW COMMENTS (0)  
Join the Conversation
Commenting policy | How to Report Abuse
If you would like your comment to be considered for a published letter to the editor, please send it to letters@post-gazette.com. Letters must be under 250 words and may be edited for length and clarity.
Partners
Advertisement
Pittsburgh Steelers owner Art Rooney II walks around the field before an NFL football game between the Denver Broncos and the Pittsburgh Steelers, Sunday, Sept. 15, 2024, in Denver.
1
sports
‘Trade Tomlin or sell the team’: Billboard put up in Pittsburgh targeting Steelers ownership
Marc Fogel with his mother Malphine.
2
news
Oakmont teacher Marc Fogel released from Russian prison after more than 3 years
U.S. Sen. elect David McCormick (R) speaks at a press conference in the Heinz Hall for the Performing Arts Garden Downtown Friday, Nov. 8, 2024, following the Associated Press declaring him the winner of his senate race against incumbent Sen. Bob Casey (D).
3
news
Sen. Dave McCormick says he supports Trump ‘100%’ as Senate readies for RFK Jr., Tulsi Gabbard confirmation votes this week
George Pickens of the Pittsburgh Steelers looks on during a game against the Cincinnati Bengals at Acrisure Stadium on January 04, 2025, in Pittsburgh, Pennsylvania.
4
sports
Ray Fittipaldo's Steelers chat transcript: 02.11.25
A pair of pedestrians stop on the Clemente Bridge to take a picture of icy conditions and snow falling on the Allegheny River Downtown Sunday Jan. 19, 2025.  #winter #weather
5
news
Pittsburgh region will avoid major impacts from winter storms this week. The weekend could be a different story.
A female Aedes aegypti mosquito is in the process of acquiring a blood meal from a human host. The Aedes aegypti mosquito is behind the large outbreaks of the Zika virus in Latin America and the Caribbean.  (James Gathany/Centers for Disease Control and Prevention via AP)
James Gathany/Centers for Disease Control and Prevention via AP
Advertisement
LATEST news
Advertisement
TOP
Email a Story